Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Better understanding Drug-Drug interactions (DDIs) is crucial for planning therapies and drugs co-administration. While, considerable efforts are spent in labor-intensive in vivo experiments and time-consuming clinical trials, understanding the pharmacological implications and adverse side-effects for some drug combinations is challenging. The majority of interactions remains undetected until therapies are prescribed to patients. We propose to use computational tools for predicting interactions in order to reduce experimental costs and improve safety. To achieve this, we will use data about the drugs and information about their biological target that are available at the beginning the drug R&D process. Our hypothesis is that artificial intelligence will improve DDI characterization and provide information earlier in the drug development process. Creating such comprehensive tool will help to reduce the risks associated to drug interactions.
François Laviolette
Rogia Kpanou
InVivo AI
Computer science
Pharmaceuticals
Université Laval
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.